Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 12351 - 12375 of 12696 in total
Name Weight StructureDescriptionCategories
Varespladib380.4

C21H20N2O5
Varespladib has been investigated for the treatment and prevention of Sickle Cell Disease, Vaso-occlusive Crisis, and Acute Coronary Syndrome.Phospholipase A2 Inhibitors / Phospholipases A, antagonists & inhibitors
Varespladib methyl394.427

C22H22N2O5
Investigated for use/treatment in atherosclerosis and coronary artery disease.Phospholipase A2 Inhibitors
Variolin B293.2834

C14H11N7O
Not AvailableAlkaloids
Varlitinib466.94

C22H19ClN6O2S
Investigated for use/treatment in cancer/tumors (unspecified).Heterocyclic Compounds, Fused-Ring / Sulfur Compounds
Varoglutamstat336.395

C19H20N4O2
Not AvailableNot Available
Vasoactive intestinal peptide3326.83

C147H237N43O43S
Not AnnotatedGastrointestinal Agents / Neuroprotective Agents / Vasodilating Agents
VasomeraNot AvailableNot AvailableExperimental Unapproved Treatments for COVID-19 / Vasodilating Agents
Vasopressin2140.46

C92H130N28O24S4
A peptide hormone used to increase blood pressure in patients with vasodilatory shock who are resistant to fluid and catecholamine therapy.Vasopressin and Analogues
Vatalanib346.813

C20H15ClN4
Used in combination with first- and second-line chemotherapy for the treatment of metastatic colorectal cancer and non-small cell lung cancer (NSCLC).Protein Kinase Inhibitors
Vatiquinone440.668

C29H44O3
Vatiquinone has been investigated for the treatment and prevention of Retinopathy, Rett Syndrome, Genetic Disease, Noise-induced Hearing Loss, and Methylmalonic Aciduria and Homocystinuria,Cblc Type.Benzoquinones / Coenzymes / Enzymes and Coenzymes / Quinones
VB-201581.772

C29H60NO8P
VB-201 is under investigation in clinical trial NCT01001468 (Study to Assess VB-201 in Patients With Psoriasis).Alcohols / Carbohydrates / Glycerophosphates / Glycerophospholipids / Lecithins / Lipids / Membrane Lipids / Phosphatidic Acids / Phosphatidylcholines / Phospholipids / Plant Extracts / Sugar Alcohols / Triose Sugar Alcohols
VB-309638.751

C33H50O12
Not AnnotatedCannabinoids and similars
VB-310638.751

C33H50O12
Not AnnotatedCannabinoids and similars
VB-311800.892

C39H60O17
Not AnnotatedCannabinoids and similars
VB-312800.892

C39H60O17
Not AnnotatedCannabinoids and similars
VB-313963.033

C45H70O22
Not AnnotatedCannabinoids and similars
Vebicorvir467.44

C19H12F3N3O4S2
Not AvailableNot Available
Vebreltinib424.391

C20H15F3N8
Not AnnotatedNot Annotated
Vecabrutinib529.92

C22H24ClF4N7O2
Vecabrutinib is under investigation in clinical trial NCT03037645 (Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers).Amines
Vecuronium557.8274

C34H57N2O4
A nondepolarizing neuromuscular blocking agent used to relax muscles or as an adjunct in general anesthesia during surgical procedures.Androstanols / Neuromuscular-Blocking Agents (Nondepolarizing) / Nicotinic Antagonists
Vedroprevir910.53

C45H60ClN7O9S
Vedroprevir has been investigated for the treatment of Hepatitis C, Chronic.Antiviral Agents
VEGFR 2 Kinase inhibitor I310.353

C18H18N2O3
Not AnnotatedNot Annotated
VEGFR2-1691073.224

C47H76N16O13
VEGFR2-169 is under investigation in clinical trial NCT00655785 (Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)).Cancer Vaccines / Vaccines, Subunit
VeglinNot AvailableInvestigated for use/treatment in cancer/tumors (unspecified) and solid tumors.Not Available
VelaferminNot AnnotatedInvestigated for use/treatment in adverse effects (chemotherapy).Amino Acids, Peptides, and Proteins / Biological Factors / Intercellular Signaling Peptides and Proteins / Peptides / Proteins
Displaying drugs 12351 - 12375 of 12696 in total